check_circleStudy Completed

Hypertension

Bayer Identifier:

14296

ClinicalTrials.gov Identifier:

NCT01118286

EudraCT Number:

Not Available

EU CT Number:

Not Available
Treatment of hypertension with Adalat® in combination with other drugs

Trial purpose

To investigate the therapeutic effectiveness of long acting nifedipine containing combination therapy in the treatment of hypertensive patients.

Key Participants Requirements

Sex

Both

Age

18 - N/A

  • - Previously untreated hypertensive patients starting with combination therapy containing nifedipine
    or
    - Insufficiently controlled hypertensive pts. receiving nifedipine as an add-on to existing non-CCB (calcium-channel-blocker) containing antihypertensive therapy

  • - None. Exclusion criteria are defined by contraindications and precautions as stated in the local product information.

Trial summary

Enrollment Goal
4497
Trial Dates
January 2010 - September 2011
Phase
N/A
Could I Receive a placebo
No
Products
Adalat CC (Nifedipine, BAYA1040)
Accepts Healthy Volunteer
No

Where to participate

StatusInstitutionLocation
Completed
Many Locations, Russia
Completed
Many Locations, Pakistan
Completed
Many Locations, Egypt
Terminated
Many Locations, Morocco
Completed
Many Locations, Saudi Arabia
Completed
Many Locations, Bahrain
Completed
Many Locations, United Arab Emirates
Completed
Many Locations, Oman
Completed
Many Locations, Jordan
Completed
Many Locations, Lebanon
Completed
Many Locations, Qatar

Primary Outcome

  • Evaluation of treatment success (lowering of blood pressure in mmHg) in adult hypertensive patients
    date_rangeTime Frame:
    After three months
    enhanced_encryption
    Safety Issue:
    No

Trial design

AdADOSE - Antihypertensive treatment with Adalat® in different doses and combination therapy
Trial Type
Observational
Intervention Type
Drug
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.